Pharmacokinetic and Pharmacodynamic (PKPD) Modeling to Determine the Andexanet Alfa Dose to Reverse the Anticoagulant Activity of Direct Fxa Inhibitors

Autor: Janet, Leeds *, Lu, Genmin *, Curnutte, John T., Conley, Pamela B., Mandema, Jaap W. *
Zdroj: In Blood 3 December 2015 126(23):1135-1135
Databáze: ScienceDirect